Inventor · disambiguated record
Daniel G. Chain
Also filed as: CHAIN DANIEL · CHAIN DANIEL G · CHAIN DANIEL GUSTAVO
11 granted patents·15 pending applications·63 citations·filing 1989–2025
88Inventor score
Files withTAUC3 BIOLOGICS LTD6INTELLECT NEUROSCIENCES INC5CERESPIR INCORPORATED4CHAIN DANIEL G3CHIESI FARMA SPA2
Top patents by PatentIndex Score
26 records- 0192US11717516B2Co-crystalsCERESPIR INCORPORATED·Filed 2022·Granted Aug 8, 2023·3 cites·11 claims
- 0290US10894822B2Treatment of tauopathiesTAUC3 BIOLOGICS LTD·Filed 2019·Granted Jan 19, 2021·4 cites·8 claims
- 0389US8703137B2Treatment of tauopathiesCHAIN DANIEL G·Filed 2012·Granted Apr 22, 2014·15 cites·44 claims
- 0487US8173127B2Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereofCHAIN DANIEL G·Filed 2002·Granted May 8, 2012·25 cites·23 claims
- 0582US2023340095A1Treatment of tauopathiesTAUC3 BIOLOGICS LTD·Filed 2023·Application pending·0 cites
- 0681US12290515B2Co-crystalsCERESPIR INCORPORATED·Filed 2023·Granted May 6, 2025·0 cites·10 claims
- 0778US12226408B2Co-crystalsCERESPIR INCORPORATED·Filed 2022·Granted Feb 18, 2025·0 cites·21 claims
- 0877US11155609B2Anti-TAUC3 antibodies and uses thereofTAUC3 BIOLOGICS LTD·Filed 2020·Granted Oct 26, 2021·1 cites·20 claims
- 0975US8697076B2Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathiesBINDER LESTER I·Filed 2012·Granted Apr 15, 2014·10 cites·19 claims
- 1075US2025034238A1Anti-tauc3 antibodies and uses thereofTAUC3 BIOLOGICS LTD·Filed 2024·Application pending·0 cites
- 1173US11673944B2Treatment of tauopathiesTAUC3 BIOLOGICS LTD·Filed 2021·Granted Jun 13, 2023·0 cites·17 claims
- 1267US12162930B2Anti-TauC3 antibodies and uses thereofTAUC3 BIOLOGICS LTD·Filed 2021·Granted Dec 10, 2024·0 cites·19 claims
- 1367US2025161290A1Co-crystalsCERESPIR INCORPORATED·Filed 2025·Application pending·0 cites
- 1458US2017253649A1Treatment of tauopathiesINTELLECT NEUROSCIENCES INC·Filed 2017·Application pending·0 cites
- 1555US2016122422A1Treatment of tauopathiesINTELLECT NEUROSCIENCES INC·Filed 2016·Application pending·0 cites
- 1654US2012244159A1Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use ThereofCHAIN DANIEL G·Filed 2012·Application pending·0 cites
- 1751US2009069258A1Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereofINTELLECT NEUROSCIENCES INC·Filed 2007·Application pending·0 cites
- 1850US2020385461A1Fusion constructs and uses thereofB PORTAL BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 1946US2014294724A1Compositions and methods for treatment of proteinopathiesINTELLECT NEUROSCIENCES INC·Filed 2012·Application pending·0 cites
- 2044US2002086847A1Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods of use thereofMINDSET BIOPHARMACEUTICALS USA·Filed 2001·Application pending·0 cites
- 2141US2004091945A1Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's DiseaseFiled 2003·Application pending·0 cites
- 2240US2011027279A1Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereofINTELLECT NEUROSCIENCES INC·Filed 2010·Application pending·0 cites
- 2339US2015065567A11-phenylalkanecarboxylic acid derivatives for the treatment of alzheimer's disease and multiple sclerosisCHIESI FARMA SPA·Filed 2014·Application pending·0 cites
- 2439US2015320706A1Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapyCHIESI FARMA SPA·Filed 2015·Application pending·0 cites
- 2535US5215888AKit for assaying the cellular integrity of blood plateletsYEDA RES & DEV·Filed 1989·Granted Jun 1, 1993·5 cites·14 claims
- 2633US2002042846A1Personal support networkFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel G. Chain files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →